PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
Recruiting · NCT05236972 · Registry updated 2022-12-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 3 | 2022-12-30 | NCT05236972 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 561 |
| Sun Yat-sen University | 606 |
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University | Guangzhou | China | 2 |